BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 10969788)

  • 1. Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.
    Huang Y; Johnson KR; Norris JS; Fan W
    Cancer Res; 2000 Aug; 60(16):4426-32. PubMed ID: 10969788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IkappaB kinase activation is involved in regulation of paclitaxel-induced apoptosis in human tumor cell lines.
    Huang Y; Fan W
    Mol Pharmacol; 2002 Jan; 61(1):105-13. PubMed ID: 11752211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids selectively inhibit paclitaxel-induced apoptosis: mechanisms and its clinical impact.
    Fan W; Sui M; Huang Y
    Curr Med Chem; 2004 Feb; 11(4):403-11. PubMed ID: 14965221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The possible correlation between activation of NF-kappaB/IkappaB pathway and the susceptibility of tumor cells to paclitaxel-induced apoptosis.
    Huang Y; Fang Y; Dziadyk JM; Norris JS; Fan W
    Oncol Res; 2002; 13(2):113-22. PubMed ID: 12392159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest.
    Dziadyk JM; Sui M; Zhu X; Fan W
    Anticancer Res; 2004; 24(1):27-36. PubMed ID: 15015572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
    Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
    Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
    Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
    Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
    Karin M; Ben-Neriah Y
    Annu Rev Immunol; 2000; 18():621-63. PubMed ID: 10837071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
    Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
    Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival.
    Lu Y; Jamieson L; Brasier AR; Fields AP
    Oncogene; 2001 Aug; 20(35):4777-92. PubMed ID: 11521190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
    Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
    Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IkappaB alpha overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-kappaB activation but not tumor necrosis factor-alpha-induced apoptosis.
    Cai Z; Körner M; Tarantino N; Chouaib S
    J Biol Chem; 1997 Jan; 272(1):96-101. PubMed ID: 8995233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1.
    Azuma M; Motegi K; Aota K; Yamashita T; Yoshida H; Sato M
    Exp Cell Res; 1999 Jul; 250(1):213-22. PubMed ID: 10388535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
    Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
    Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-induced immune suppression is associated with NF-kappaB activation via conventional PKC isotypes in lipopolysaccharide-stimulated 70Z/3 pre-B lymphocyte tumor cells.
    Lee M; Jeon YJ
    Mol Pharmacol; 2001 Feb; 59(2):248-53. PubMed ID: 11160860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
    Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
    Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway.
    Sethi G; Ahn KS; Sandur SK; Lin X; Chaturvedi MM; Aggarwal BB
    J Biol Chem; 2006 Aug; 281(33):23425-35. PubMed ID: 16785236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
    Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
    Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.